Esperion is dedicated to discovering, developing and commercializing innovative and combination medicines to reduce cardiovascular risk.
Figuring out this essential mineral for heart and bone health can seem daunting – unless you follow this expert advice.
The ASPC 2024 Congress on CVD Prevention will be held in-person at the Hyatt Regency Salt Lake City from August 2-4, 2024! Our 2024 scientific…
The CardioNerds Obesity series discusses Lifestyle and Pharmacologic Management of Obesity with Dr. Ambarish Pandey.
The ASPC 2024 Congress on CVD Prevention will be held in-person at the Hyatt Regency Salt Lake City from August 2-4, 2024! Our 2024 scientific…
The ASPC 2024 Congress on CVD Prevention will be held in-person at the Hyatt Regency Salt Lake City from August 2-4, 2024! Our 2024 scientific…
The CardioNerds Obesity series discusses Obesity & Cardiovascular Disease Risk with Dr. Jaime Almandoz
Actions on S.Res.496 – 118th Congress (2023-2024): A resolution designating September 2023 as “National Cholesterol Education Month” and September 30, 2023, as LDL-C Awareness Day.
U.S. Food and Drug Administration (FDA) Clears Investigational New Drug Application for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia (HeFH) Collaboration with Eli Lilly and…
Join PACH & ASPC for a forum discussing patient access and innovation in Philadelphia.
